2 completed, 2 recruiting, 1 active not recruiting, 1 not yet recruiting. 7 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 7 | Completed 2, Recruiting 2, Active not recruiting 1, Not yet recruiting 1, Terminated 1 |
Follow Chemotherapy: new trials by email Literature Review of Chemotherapy trials Research Report on Chemotherapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| [18F]-AraG PET Imaging in LA HNSCC [18F]-AraG radiotracer, Chemotherapy, Radiotherapy - Head and Neck Squamous Cell Carcinoma (HNSCC), Locally Advanced Head and Neck Squamous Cell Carcinoma | Early Phase 1 | Not yet recruiting | Indiana University | 5 | 2026-09-01 | 2026-07-22 |
| Study of Neoantigen mRNA Vaccines in Patients With Resectable Pancreatic Cancer Surgery, Camrelizumab, SJ-Neo006 - Pancreatic Cancer | Early Phase 1 | Recruiting | Jinling Hospital, China | 12 | 2024-04-01 | 2024-03-22 |
| Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer Chemotherapy, Patient Observation, Questionnaire Administration - Rectal Adenocarcinoma, Stage II Rectal Cancer AJCC v8 | Early Phase 1 | Recruiting | M.D. Anderson Cancer Center | 120 | 2024-03-13 | 2026-05-20 |
| Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery Chemotherapy, Olaparib, Therapeutic Conventional Surgery - BRCA-Mutated Ovarian Carcinoma, BRCA1 Gene Mutation | Early Phase 1 | Active not recruiting | M.D. Anderson Cancer Center | 15 | 2019-06-07 | 2026-08-12 |
| Tumor-Specific Clonotype, Metabolic Profile, and PET/CT in Predicting Chemotherapy Response in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma Chemotherapy, Computed Tomography, Fludeoxyglucose F-18 - Recurrent Diffuse Large B-Cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma | Early Phase 1 | Completed | M.D. Anderson Cancer Center | 35 | 2015-10-13 | 2022-10-28 |
| Pilot, Neoadjuvant Gemcitabine and Abraxane Chemotherapy Followed by Surgery, Adenocarcinoma of the Pancreas Surgery, Genetic Expression, Chemotherapy - Adenocarcinoma Pancreas | Early Phase 1 | Terminated | Medical University of South Carolina | 2 | 2012-07-01 | 2016-03-08 |
| Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Chemotherapy, Propranolol Hydrochloride, Quality-of-Life Assessment - Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma | Early Phase 1 | Completed | M.D. Anderson Cancer Center | 32 | 2012-03-09 | 2019-08-29 |
Fallopian Tube Neoplasms (2) · Lymphoma, Large B-Cell, Diffuse (1) · Ovarian Neoplasms (1) · Pancreatic Neoplasms (1) · Rectal Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1)
M.D. Anderson Cancer Center (4) · Indiana University (1) · Jinling Hospital, China (1) · Medical University of South Carolina (1)
United States (6) · China (1)
Eric Kimchi, MD (1) · George Chang (1) · Jason Westin (1) · Lois M Ramondetta (1) · Richard Zellars, MD (1) · Shannon N Westin (1) · Xinbo Wang, MD (1)
P30CA016672 (1)